Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes- NEOART Study.

NCT04145544 is registered in ClinicalTrials.gov with Nurami Medical Ltd as lead sponsor.

NCT NCT04145544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04145544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes- NEOART Study.
Lead sponsor
Nurami Medical Ltd
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2020
Completion date
November 1, 2022
Enrollment
92 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrospinal fluid leak, dural tear